Member access

4-Traders Homepage  >  Shares  >  Mercato Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

46
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercato Continuo Espanol
09/17/2014 09/18/2014 09/19/2014 09/22/2014 09/23/2014 Date
32.8(c) 33(c) 33.12(c) 32.68(c) 32.555 Last
1 347 469 958 994 1 251 209 961 189 1 529 131 Volume
+1.03% +0.61% +0.36% -1.33% -0.38% Change
More quotes
Company
Grifols SA operates as a fractionator of plasma derived blood products.The company operates through four segments: Bioessence, Hospital, Diagnostic and Raw Materials.The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital... 
Sector
Pharmaceuticals
Calendar
10/29Earnings Release
Surperformance© rating of Grifols SA
Trading Rating : Investor Rating :
More about the company
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 457 M
EBIT 2014 913 M
Net income 2014 483 M
Debt 2014 3 148 M
Yield 2014 1,65%
Sales 2015 3 675 M
EBIT 2015 988 M
Net income 2015 538 M
Debt 2015 2 889 M
Yield 2015 1,97%
PER 2014 22,71
PER 2015 20,00
EV / Sales 2014 4,01x
EV / Sales 2015 3,70x
Capitalization 10 709 M
More Financials
Latest news on GRIFOLS SA
1d ago GRIFOLS : acquires 50% of the share capital of Kiro Robotics for 21 million euro..
4d ago GRIFOLS : acquires 50% of the share capital of Kiro Robotics for 21 million euro..
08/14 ARADIGM : Announces Second Quarter 2014 Financial Results
07/31 GRIFOLS : rsquo; net profit rises by 23% to 224.8 million euros in the First Hal..
07/28 HOLOGIC : GRIFOLS -New highly sensitive test to screen donors of blood, tissues,..
07/25 GRIFOLS : New highly sensitive test to screen donors of blood, tissues, and orga..
07/10 GRIFOLS : Therapeutics Assigned Patent
07/01 GRIFOLS : Award Winners at the Seventh Edition of the Martín Villar Research Awa..
06/30 GRIFOLS : improves safety of transfusions with its ID CORE XT diagnostic kit
06/30 GRIFOLS : Therapeutics Assigned Patent
06/23 GRIFOLS : launches a continuing education program for transfusion medicine profe..
06/18 GRIFOLS : opens state-of-the-art facility in Clayton, NC to help advance treatme..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
Grifols SA : Income Statement Evolution
More Financials
EPS Revisions
Grifols SA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF